RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING

Show other versions (1)

The problem of vascular aging is discussed. Special attention among the signs of vascular aging is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation and oxidative stress, as well as to its relation to replicative cellular senescence. Potential rou...

Full description

Bibliographic Details
Main Authors:	V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	vascular aging the renin-angiotensin-aldosterone system replicative cellular aging
Online Access:	https://www.rpcardio.online/jour/article/view/257

Similar Items

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconception cohort
by: D. Aoulad Fares, et al.
Published: (2023-12-01)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
by: N.D. Filipets, et al.
Published: (2019-02-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism
by: Liubov G. Yanevskaya, et al.
Published: (2021-12-01)

Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma
by: Soo Ji Jeon, et al.
Published: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
by: Anastasia V. Poznyak, et al.
Published: (2021-06-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

CLINICAL ASSOCIATIONS BETWEEN CORONAVIRUS INFECTION (COVID-19) AND ARTERIAL HYPERTENSION: PATHOGENETIC MECHANISMS AND DISCUSSION ON THE USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
by: Yakubava L. V., et al.
Published: (2020-11-01)

Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences
by: Agnieszka Dettlaff-Pokora, et al.
Published: (2021-04-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Bidirectional relationship between covid-19 and diabetes: Role of renin–angiotensin–aldosterone system and drugs modulating it
by: Razia Khanam
Published: (2021-01-01)

The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
by: Eugenie R. Lumbers, et al.
Published: (2022-02-01)

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
by: Juan José García Martínez, et al.
Published: (2022-11-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

Role of renin–angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients
by: Minako Inoue, et al.
Published: (2018-10-01)

Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
by: Joshua J. Joseph, et al.
Published: (2018-09-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension
by: Yang Liu, et al.
Published: (2020-06-01)

A New Perspective on the Renin-Angiotensin System
by: Adrian Martyniak, et al.
Published: (2022-12-01)

Molecular Mechanisms Underlying Renin-Angiotensin-Aldosterone System Mediated Regulation of BK Channels
by: Zhen-Ye Zhang, et al.
Published: (2017-09-01)

Regulation of human salt-sensitivite hypertension by myeloid cell renin-angiotensin-aldosterone system
by: Lale A. Ertuglu, et al.
Published: (2023-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)